Self-administration of Cocaine-remifentanil Mixtures by Monkeys: an Isobolographic Analysis
Overview
Affiliations
Rationale: Abuse of mixtures of stimulants and opioids ("speedball") is common. Although this combination has been studied in the laboratory, conclusions about the nature of the cocaine/opioid interaction have been mixed.
Objectives: The objectives of the present experiment were to allow monkeys to self-administer mixtures of cocaine and the mu opioid agonist remifentanil and to quantify the interaction using the isobolographic approach. Our hypothesis was that the drugs would be super-additive in their reinforcing effects.
Materials And Methods: Rhesus monkeys (n = 5) prepared with i.v. catheters were allowed to self-administer cocaine or saline under a progressive-ratio schedule. When responding was stable, doses of cocaine or remifentanil were made available in test sessions. Next, mixtures of doses of the drugs were tested over a range of doses in 1:1, 1:2, and 2:1 ratios of their ED(50)s. Results were analyzed using isobolographic techniques.
Results: Both drugs alone and all drug mixtures functioned as positive reinforcers in a dose-related manner. Cocaine maintained more responding at maximum than did remifentanil, i.e., was a stronger reinforcer. The experimentally determined equi-effective dose for the 1:1 and 1:2 cocaine/remifentanil mixtures tended toward super-additivity, but the difference from additivity did not achieve statistical significance. The 2:1 mixture was super-additive. Maximum responding maintained by the mixtures was higher than that maintained by remifentanil but not different from cocaine.
Conclusions: Combinations of cocaine and remifentanil can be additive or super-additive as positive reinforcers, depending on proportions of each. Interactions between stimulants and opioids may contribute to the abuse of these mixtures.
Berro L, Zamarripa C, Rowlett J J Pharmacol Exp Ther. 2022; 383(3):199-207.
PMID: 36153004 PMC: 9667979. DOI: 10.1124/jpet.122.001191.
Seaman Jr R, Lordson C, Collins G Front Psychiatry. 2022; 13:814574.
PMID: 35237191 PMC: 8884160. DOI: 10.3389/fpsyt.2022.814574.
Application of dose-addition analyses to characterize the abuse-related effects of drug mixtures.
Doyle M, Gannon B, Mesmin M, Collins G J Exp Anal Behav. 2022; 117(3):442-456.
PMID: 35142382 PMC: 9327442. DOI: 10.1002/jeab.741.
Novel Synthetic Opioids: The Pathologist's Point of View.
Frisoni P, Bacchio E, Bilel S, Talarico A, Gaudio R, Barbieri M Brain Sci. 2018; 8(9).
PMID: 30200549 PMC: 6162684. DOI: 10.3390/brainsci8090170.
Maguire D, France C Psychopharmacology (Berl). 2018; 235(8):2357-2365.
PMID: 29860612 PMC: 6045955. DOI: 10.1007/s00213-018-4932-6.